Laura V. Diness
Copenhagen, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Effect of one or two cycles of dual immunotherapy with nivolumab and ipilimumab in patients with mismatch repair-deficient rectal cancer (RESET-R): interim results from a multicentre, single-arm, phase 2 trial.
Journal: The lancet. Gastroenterology & hepatology
Published: January 21, 2026
Risk factors for distant recurrence in patients with rectal cancer supporting selection for total neoadjuvant therapy.
Journal: Acta oncologica (Stockholm, Sweden)
Published: December 10, 2025
Acute toxicity and quality of life in dose-escalated proton reirradiation for locally recurrent rectal cancer: The prospective ReRad II trial.
Journal: Clinical and translational radiation oncology
Published: June 20, 2025
Defining and sparing sexual function-related organs at risk for rectal cancer radiotherapy.
Journal: Acta oncologica (Stockholm, Sweden)
Published: May 30, 2025
Efficacy and Safety of Capecitabine, Irinotecan, Gemcitabine, and Bevacizumab as Second-Line Treatment in Advanced Biliary Tract Cancer: A Phase II Study.
Journal: Oncology
Published: March 23, 2017
Procalcitonin and C-reactive protein as markers of bacterial infection in patients with solid tumours.
Journal: Danish medical journal
Published: December 03, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026